<DOC>
	<DOCNO>NCT02073409</DOCNO>
	<brief_summary>Isolation nontuberculous mycobacteria ( NTM ) sputa cystic fibrosis ( CF ) patient relatively common , uncertain significance . At request CF Foundation ( CFF ) , Investigators design standardized diagnostic protocol base current recommendation diagnosis NTM American Thoracic Society , well forthcoming recommendation CFF European CF Society . The study observational nature , intend change current diagnostic approach infection , rather standardized collection data facilitate decision make process . When validate , protocol easily assessable entire CFF Care Center Network .</brief_summary>
	<brief_title>PREDICT Trial : PRospective Evaluation NTM Disease In CysTic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . Male female subject confirm diagnosis CF , define : sweat chloride value â‰¥60 mmol/L quantitative pilocarpine iontophoresis , OR 2 CF cause mutation ( document subject 's medical record ) , AND chronic sinopulmonary disease OR gastrointestinal/nutritional abnormality 2 . Age 7 year great . 3 . Able understand comply protocol requirement , restriction , instruction likely complete study plan , judge investigator . 4 . Signed ICF , appropriate , sign assent form . 5 . Recent positive sputum culture BAL NTM . 6 . Previous sign ICF allow medical record enter CF Foundation Patient Registry . 1 . Presence condition abnormality opinion investigator would compromise safety subject quality data . 2 . Pregnant . 3 . History solid organ hematological transplantation . 4 . Currently undergo treatment NTM infection . 5 . Patient treatment failure current NTM specie , define positive sputum culture within 12 month discontinuation antibiotic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Nontuberculous Mycobacteria</keyword>
</DOC>